The Asset Lead Medical Director will lead development and delivery of U.S. Cardiovascular & Metabolic (CVM) Medical strategy for maridebart cafraglutide (MariTide), an investigational therapy being studied for obesity and obesity-related conditions. The role will establish the cross-indication scientific, evidence, stakeholder, and implementation foundation to support chronic weight management (CWM) launch readiness and prepare the organization for maturation in CVM. In partnership with the U.S. Medical Portfolio Lead, TA Head, Global Medical, and cross-functional colleagues, the role will translate global strategy into an integrated U.S. Medical plan. The position will work across medical strategy, evidence generation, stakeholder engagement, scientific communications, clinical trial support, launch readiness, and governance. It will also ensure Medical activities comply with applicable laws, regulations, policies, and standard operating procedures, and use planning and performance-management processes to track progress, identify risks, and improve execution.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior